Pibrentasvir (CAS 1353900-92-1)

« Back to Anti-Hepatitis API

Pibrentasvir

CAS No. 1353900-92-1
哌仑他韦
Pibrentasvir structure
Chemical structure
CAS No.1353900-92-1
SynonymsN,N'-[[(2R,5R)-1-[3,5-Difluoro-4-[4-(4-fluorophenyl)-1-piperidinyl]phenyl]-2,5-pyrrolidinediyl]bis[(6-fluoro-1H-benzimidazole-5,2-diyl)-(2S)-2,1-pyrrolidinediyl[(1S)-1-[(1R)-1-methoxyethyl]-2-oxo-2,1-ethanediyl]]]biscarbamic acid C,C'-dimethyl ester; A 1325912.0; ABT 530
CategoryAnti-Hepatitis API / Anti-Hepatitis
Assay / Purity99%
Molecular FormulaC57H65F5N10O8
Molecular Weight1113.2
Melting Point—
Boiling Point—
Density—
Flash Point—
AppearanceOff-white to white solid powder

Application and positioning

Pibrentasvir is an NS5A inhibitor supplied as the free base. It is used in pangenotypic direct-acting antiviral tablets for chronic hepatitis C, in fixed-dose combination with glecaprevir. Laurand supplies it from audited Chinese production partners for pharmaceutical manufacturing and process development.

Quality and documentation

  • Batch-specific Certificate of Analysis issued by the manufacturing site
  • SDS/MSDS and specification sheet available on request
  • Residual solvents and elemental impurities statements discussed per project
  • For pharmaceutical manufacturing and R&D use only — not for direct administration

Packaging and handling

  • Packed in double polyethylene-lined fibre drums; pack size confirmed at quotation
  • Small quantities in sealed aluminium foil bags
  • Palletised for air and sea freight; store dry, ventilated and protected from light

Related products

Specifications shown are indicative. The final specification and documentation package are confirmed with the quotation.

Interested in this product?

Contact us for price, COA, MSDS and lead time — custom synthesis available.

Request a Quote

Reference: CAS 1353900-92-1 · PubChem CID 58031952